Atlas Trials

Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects

Clinical trial NCT00544921 · COMPLETED

Trial details

NCT number
NCT00544921
Sponsor
Glycadia
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes
Start date
2005-10-01
Primary completion
2006-10-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.